Related Experiment Videos
Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas
International Journal of Cancer
|March 15, 1978
Abstract:
Methylcholanthrene-induced sarcomas of BALB/c mice express unique tumor specific transplantation antigens (TSTA), and weaker, common TSTA. Antigens of endogenous murine leukemia virus (MuLV) expressed by some of these tumors cannot completely account for these common TSTA. However, MuLV antigens on the immunizing tumor appear to increase the immunogenicity of the common TSTA.
Insights
Methylcholanthrene-induced sarcomas in mice have unique and common tumor specific transplantation antigens (TSTA). Murine leukemia virus (MuLV) antigens boost the immune response to these common TSTA.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- Methylcholanthrene-induced sarcomas in BALB/c mice present distinct tumor-specific transplantation antigens (TSTA).
- These tumors also express weaker, shared TSTA recognized across different tumors.
- The role of endogenous murine leukemia virus (MuLV) antigens in TSTA expression is not fully understood.
Purpose of the Study:
- To investigate the nature of tumor-specific transplantation antigens (TSTA) in methylcholanthrene-induced sarcomas.
- To determine the contribution of murine leukemia virus (MuLV) antigens to common TSTA.
- To assess the impact of MuLV antigens on the immunogenicity of common TSTA.
Main Methods:
- Induction of sarcomas in BALB/c mice using methylcholanthrene.
- Analysis of tumor-specific transplantation antigens (TSTA) using transplantation assays.
- Detection and characterization of murine leukemia virus (MuLV) antigens on tumor cells.
Main Results:
- Methylcholanthrene-induced sarcomas exhibit both unique and common TSTA.
- Endogenous MuLV antigens are expressed by some of these tumors but do not fully explain the common TSTA.
- The presence of MuLV antigens on the immunizing tumor enhances the immunogenicity of the common TSTA.
Conclusions:
- Tumor-specific transplantation antigens (TSTA) in methylcholanthrene sarcomas are complex, involving both unique and shared components.
- While MuLV antigens contribute to the tumor antigen profile, they are not the sole source of common TSTA.
- Co-expression of MuLV antigens can significantly augment the immune response against shared tumor antigens, suggesting potential therapeutic implications.